Enterprise Tech Ecosystem Series - Johnson & Johnson
Summary
Johnson & Johnson (J&J) provides pharmaceuticals in the immunology, cancer, neuroscience, infectious, cardiovascular and metabolic disease areas through its subsidiary ‘Janssen Pharmaceutica’.
Scope
The report provides information and insights into Johnson & Johnson's including -
Reasons to buy
Summary
Johnson & Johnson (J&J) provides pharmaceuticals in the immunology, cancer, neuroscience, infectious, cardiovascular and metabolic disease areas through its subsidiary ‘Janssen Pharmaceutica’.
Scope
The report provides information and insights into Johnson & Johnson's including -
- Insights of its digital transformation strategies
- Details of various partnerships, network map, in-house launches, and other industry innovation programs
- Detailed overview of Johnson & Johnson's technology centers and innovation programs and financial highlights.
Reasons to buy
- Gain insights into Johnson & Johnson's technology innovations.
- Gain insights into its Digital Transformation Strategy.
- Gain insights into various product launches, partnership strategies of Johnson & Johnson.
- Gain insights into various disruptive technologies and tech initiatives of the Company.
Table of Contents
- Overview
- Digital Transformation Strategy
- Technology Centers and Innovation Programs
- Technology Focus
- Technology Initiatives
- Johnson & Johnson Development Corp. (JJDC) - A Venture Capital Arm
- JJDC Investments
- Acquisitions
- Partner, Investment, and Acquisition Network Map
- ICT Budget & Contracts
- Key Executives
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- SAP
- Inkbit
- HP
- Capgemini
- Carbon
- IBM
- Iktos
- Organovo
- medopad
- AWS
